IntelGenx Corp.
OTC Bulletin Board : IGXT

IntelGenx Corp.

December 13, 2006 14:51 ET

IntelGenx Technologies Corp. Approved for Listing on OTCBB

SAINT LAURENT, QUEBEC--(CCNMatthews - Dec. 13, 2006) - IntelGenx Technologies Corporation (OTCBB:IGXT)("IntelGenx" or the "Company") is pleased to announce that the National Association of Securities Dealers, Inc. (NASD®) has approved the Company's application for the listing of its common shares for trading under the trading symbol "IGXT".

Horst Zerbe, President and CEO, said "We are very excited about our listing on the OTCBB. The listing represents a significant milestone in our corporate growth strategy and we expect to enhance shareholder value as a result of the listing".

ABOUT INTELGENX CORP.

IntelGenx Corp. is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The company uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastro-intestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. The company's research and development pipeline includes products for the treatment of osteoarthritis, pain management, smoking cessation, and seasonal affective disorder.


ON BEHALF OF THE BOARD OF DIRECTORS:

Dr. Horst G.Zerbe, President and CEO

The OTCBB has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information